Preferred Label : Salmeterol Xinafoate;
MeSH definition : A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR
when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC
OBSTRUCTIVE PULMONARY DISEASE.;
MeSH synonym : Xinafoate, Salmeterol;
MeSH Hyperonym : Salmeterol;
MeSH hyponym : Serevent;
MeSH Related Number : 2I4BC502BT (Salmeterol);
Wikipedia link : https://en.wikipedia.org/wiki/Serevent;
Is substance : O;
UNII : 6EW8Q962A5;
Origin ID : D000068299;
UMLS CUI : C0245531;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Exact mapping(s) to DCI
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT
A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR
when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC
OBSTRUCTIVE PULMONARY DISEASE.
https://www.cochrane.org/fr/CD007694/AIRWAYS_les-personnes-asthmatiques-ont-elles-moins-deffets-indesirables-graves-lorsquelles-prennent-du
2021
false
true
false
United Kingdom
France
Asthma chronic
corticosteroid therapy
adrenal cortex hormones
Formoterol Fumarate
Salmeterol Xinafoate
treatment outcome
review of literature
french abstract
asthma
administration, inhalation
adrenal cortex hormones
---
http://www.cochrane.org/fr/CD006363
2013
false
true
false
United Kingdom
France
treatment outcome
Salmeterol Xinafoate
Salmeterol Xinafoate
albuterol
placebos
review of literature
french abstract
asthma
---
http://www.cochrane.org/fr/CD007695
2013
false
United Kingdom
France
French
Asthma chronic
Formoterol Fumarate
Salmeterol Xinafoate
meta-analysis
asthma
chronic disease
anti-asthmatic agents
bronchodilator agents
adrenergic beta-2 receptor agonists
french abstract
---
http://www.has-sante.fr/portail/jcms/c_1029066/serevent-serevent-diskus
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-03/serevent_serevent_diskus_-_ct-_8060.pdf
2011
false
France
French
Salmeterol Xinafoate
Salmeterol Xinafoate
administration, inhalation
bronchodilator agents
receptors, adrenergic, beta-2
insurance, health, reimbursement
pulmonary disease, chronic obstructive
asthma
asthma, exercise-induced
treatment outcome
bronchodilator agents
meta-analysis as topic
salmeterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
evaluation of the transparency committee
---
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Salmeterol.aspx
http://www.aboutkidshealth.ca/en/healthaz/drugs/pages/salmeterol.aspx?k=salm%c3%a9t%c3%a9rol;+asthme
2010
false
Canada
English
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Salmeterol Xinafoate
Fluticasone-Salmeterol Drug Combination
child
bronchodilator agents
bronchodilator agents
drug combinations
androstadienes
glucocorticoids
salmeterol and fluticasone
salmeterol
administration, inhalation
drug information
patient education handout
---
http://www.lecrat.eu/?s=Salm%C3%A9t%C3%A9rol
2009
false
France
French
Salmeterol Xinafoate
pregnancy
adrenergic beta-agonists
breast feeding
bronchodilator agents
salmeterol
drug information
---
http://www.cochrane.org/fr/CD006922
2009
false
true
false
France
United Kingdom
Asthma chronic
treatment outcome
Salmeterol Xinafoate
review of literature
french abstract
asthma
steroids
---
https://www.revmed.ch/RMS/2009/RMS-188/Effets-secondaires-severes-du-traitement-de-l-asthme-le-salmeterol-seul-augmente-le-risque
2009
false
Switzerland
French
corticosteroid therapy
Salmeterol Xinafoate
Salmeterol Xinafoate
adrenergic beta-agonists
bronchodilator agents
asthma
critical appraisal or critical reading
meta-analysis
---
https://minerva-ebp.be/fr/article/541
2008
false
false
minerva-ebm.be
Belgium
French
Adrenocortical steroid therapy
corticosteroid therapy
Salmeterol Xinafoate
Tiotropium Bromide
pulmonary disease, chronic obstructive
bronchodilator agents
administration, inhalation
adrenal cortex hormones
treatment outcome
drug therapy, combination
scopolamine derivatives
critical appraisal or critical reading
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67274478
2008
false
France
French
Salmeterol Xinafoate
suspensions
administration, inhalation
salmeterol
drug information
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69163238
2008
false
France
French
Salmeterol Xinafoate
salmeterol
administration, inhalation
powders
drug information
---
https://minerva-ebp.be/fr/article/598
2007
false
false
minerva-ebm.be
Belgium
French
Fluticasone-Salmeterol Drug Combination
Fluticasone
Salmeterol Xinafoate
Tiotropium Bromide
comparative study
bronchodilator agents
pulmonary disease, chronic obstructive
androstadienes
drug therapy, combination
treatment outcome
critical appraisal or critical reading
---
http://www.has-sante.fr/portail/display.jsp?id=c_460221
2006
false
France
French
Salmeterol Xinafoate
adrenergic beta-agonists
bronchodilator agents
administration, inhalation
insurance, health, reimbursement
pulmonary disease, chronic obstructive
adult
salmeterol
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400229
2005
false
France
French
Salmeterol Xinafoate
adrenergic beta-agonists
bronchodilator agents
administration, inhalation
insurance, health, reimbursement
asthma
pulmonary disease, chronic obstructive
adult
child
adolescent
salmeterol
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_399986
2004
false
France
French
Salmeterol Xinafoate
salmeterol
adrenergic beta-agonists
bronchodilator agents
administration, inhalation
insurance, health, reimbursement
asthma
pulmonary disease, chronic obstructive
adult
child
adolescent
treatment outcome
comparative study
evaluation of the transparency committee
---